The dual inhibition of αvβ3 integrin and TβRI in the GBM microenvironment suppresses endothelial cell proliferation and M2 macrophage polarization, which is an interesting adjuvant therapeutic target in GBM treatment [114]. Here, TGFBR1 is linked to glioblastoma.